State of Tennessee, Department of Treasury
ICPT

State of Tennessee, Department of Treasury’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

State of Tennessee, Department of Treasury’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-31,156
Closed -$8.79M – 1460
2015
Q1 		$8.79M Buy
+31,156
New +$6.75M 0.05% 400

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

State of Tennessee, Department of Treasury's ICPT Position: Q2 2015 in Review

State of Tennessee, Department of Treasury sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2015, closing a stake of 31,156 shares — an estimated $8.79M sold.

State of Tennessee, Department of Treasury first reported a position in ICPT in Q1 2015 and held it in 1 quarter. The position peaked at $8.79M in Q1 2015. 191 funds tracked by Wall St. Rank hold ICPT as of Q2 2015.

  • State of Tennessee, Department of Treasury reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • State of Tennessee, Department of Treasury sold 31,156 Intercept Pharmaceuticals, Inc. shares in Q2 2015, an estimated $8.79M.
  • State of Tennessee, Department of Treasury first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2015 and held it in 1 quarter.
  • State of Tennessee, Department of Treasury's Intercept Pharmaceuticals, Inc. position peaked at $8.79M in Q1 2015.
  • 191 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2015.

Based on State of Tennessee, Department of Treasury's 13F filing for Q2 2015, filed 10 Aug 2015.